Detalles de la búsqueda
1.
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
HIV Med;
24(8): 933-937, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016556
2.
Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinine.
HIV Med;
20(10): 648-656, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31321875
3.
Switching to dual antiretroviral regimens is associated with improvement or no changes in activation and inflammation markers in virologically suppressed HIV-1-infected patients: the TRILOBITHE pilot study.
HIV Med;
20(8): 555-560, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31131528
4.
Switching to abacavir versus use of a nucleoside-sparing dual regimen for HIV-infected patients with tenofovir-associated renal toxicity.
HIV Med;
2018 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932293
5.
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
HIV Med;
17(1): 62-7, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26122981
6.
The influence of patient beliefs and treatment satisfaction on the discontinuation of current first-line antiretroviral regimens.
HIV Med;
17(1): 46-55, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26149493
7.
Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Eur J Neurol;
23(5): 919-25, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26914970
8.
Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
HIV Med;
16(4): 240-8, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25604328
9.
High levels of CD4⺠CTLA-4⺠Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.
Eur J Clin Microbiol Infect Dis;
34(2): 267-75, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25142804
10.
Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.
Osteoporos Int;
25(3): 1071-9, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24057480
11.
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era.
Eur J Clin Microbiol Infect Dis;
33(2): 179-87, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23948752
12.
Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.
J Viral Hepat;
20(12): 829-37, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304452
13.
Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.
Transplant Proc;
40(10): 3810-2, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19100499
14.
Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age.
Arch Osteoporos;
13(1): 56, 2018 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29736771
15.
Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen.
HIV Clin Trials;
7(4): 210-4, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17065033
16.
Pneumococcal vaccination in adult people living with HIV on suppressive antiretroviral therapy: a case-control study.
Int J STD AIDS;
31(2): 174-182, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31865862
17.
Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.
AIDS;
13(12): 1497-502, 1999 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-10465073
18.
Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients.
AIDS;
12(11): F131-5, 1998 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-9708403
19.
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen.
AIDS;
14(2): F1-7, 2000 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-10708276
20.
Phenotypic testing predicts virological response in successive protease inhibitor-based regimens.
AIDS;
14(9): F95-101, 2000 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-10894269